ACOX1 and Hepatic steatosis: The findings of our study demonstrated that catalpol treatment enhanced fatty acid oxidation by activating PPARα-mediated gene transcription and improving CPT1 and ACOX1 activity, thereby attenuating hepatic steatosis.